It is not known whether the same mechanisms are responsible for the reduction in cancer incidence and for suppression of established cancer growth, but emerging evidence points to alterations in immune cell phenotypes and/or reduction in circulating insulin that accompanies improved glucose tolerance. The gene discussed is INS; the disease is cancer.